Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
160 Leser
Artikel bewerten:
(0)

Pharmacist Andrew Hanna Named the Transitions in Care Working Group Lead for the Champlain Regional Pharmacist Committee

CORNWALL, ON / ACCESSWIRE / November 30, 2020 / Andrew Hanna, a dedicated compound pharmacist and active member of his community, has been named the Transitions in Care Working Group Lead for the Champlain Regional Pharmacist Committee (CRPhC).

Established in 2016 by the Champlain Local Health Integration Network (LHIN), the CRPhC primarily focuses on enhancing and optimizing the critical function that pharmacists perform in ensuring patients have access to comprehensive, high quality care. The committee and its associated working groups are made up of members who are affiliated with a wide range of provincial and national health networks, and work in hospital environments, community settings, and Family Health Teams.

As Lead for the CRPhC's Transitions in Care Working Group, Andrew Hanna will work closely and collaboratively with his fellow members, as well as stakeholders across the broader healthcare landscape, to highlight both opportunities and gaps across the multitude of policies, protocols and processes that govern the transition of patients from hospital to home.

"I am honored to be named by my peers for this important role with the CRPhC," commented Andrew Hanna, who practices in Cornwall, Ontario, and is an expert in pharmaceutical compounding and has patent pending medication through the FDA. "It is critical that we ensure patients have the information, support and resources they need to successfully make the journey from the hospital setting to their home. To achieve this goal, all healthcare providers need to work closely together in a manner that is efficient, streamlined, standardized, compliant, and demonstrably patient-centric."

Continued Andrew Hanna, who earned his BSc in Pharmacy at the University of Toronto, and subsequently completed post-graduate placements in Winnipeg and Ottawa: "I am also inspired to work with the exceptional professionals at the CRPhC to shine a brighter spotlight on the vital work that pharmacists do in the community each and every day. Pharmacists are certainly not just order takers. They are competent, caring and trustworthy members of their patients' healthcare team, and play a pivotal role in optimizing treatment plans that support healthier lives."

About Andrew Hanna

Andrew Hanna is a certified compounding pharmacist, and the founder of Cotton Mill Pharmacy: a specialty pharmacy that compounds prescriptions for clients with complex pharmaceutical needs. In addition, Andrew is a Medical Cannabis Consultant who helps patients access, or learn about accessing, obtaining cannabis for medical purposes such as pain relief, nerve pain, and mental health. Andrew prides himself on bridging the gap between patients and doctors, providing affordable and quality pharmaceutical care, and maintaining a personal and supportive relationship with each and every one of his patients.

CONTACT:

Andrew Hanna
info@Cottonmillpharmacy.com
Tel: +1 613-936-0000
Fax: +1 613-936-0008
Mon - Fri: 7am - 7pm
??Saturday: 9am - 5pm
?Sunday: Closed

SOURCE: Andrew Hanna



View source version on accesswire.com:
https://www.accesswire.com/618786/Pharmacist-Andrew-Hanna-Named-the-Transitions-in-Care-Working-Group-Lead-for-the-Champlain-Regional-Pharmacist-Committee

© 2020 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.